I certainly hope so, but just like with so many things in life the difference between the hype and the reality is a bit sobering. Although there had already been a few promising small trials with CGMS the first big randomized controlled trial in patients with type 1 diabetes was published on September 8th 2008 in the New England Journal of Medicine (a very prestigious and respected medical journal). Let me describe the study and then try to explain what the results mean.
At 10 different medical centers 322 patients with diabetes were randomly assigned to use one of three CGMS devices (The DexCom Seven, the Minimed Paradigm, or the Freestyle Navigator) or to continue with traditional finger stick blood glucose testing only. They were divided into three age groups (8-14yo, 15-24yo and 25 or older, the average age in this last group was 44yo). The average HbA1c level in these patients before the study started was between 7.6-8.0%. They were already doing an average of six finger stick blood glucose tests a day. They were mostly well-educated (three quarters of the patients or the parents of the kids had college degrees). They were all doing intensive insulin treatment (80% were using an insulin pump and the other 20% were taking multiple insulin shots a day of both long-acting and fast-acting insulins). In other words this was a highly motivated group of people who would be expected to do really well.
They were seen seven times in person during a six month period of the study. In addition they had seven scheduled phone visits with the research team in between their in-person visits. During these visits they were given advice and suggestions for how to interpret their glucose results and encouragement to change their insulin treatment and food and exercise to help keep their blood glucose as close to normal as they could while trying to avoid going too low (hypoglycemia).
Given everything that I have said the results were quite disappointing. At the end of six months the only group who showed a significant improvement in their average blood glucose control were the older adults who got a drop of HbA1c of about half a percentage point (0.5%). The group aged 8-14yo and 15-24yo showed no improvement in HbA1c compared to the people who continued to use traditional finger stick tests only. Even more surprising to me was that none of the groups using CGMS had significantly fewer low blood glucose episodes (hypoglycemia).
What can we make of this? It tells us that if you are highly motivated and are using frequent traditional finger stick blood glucose testing then you can achieve really good blood glucose control and that adding a continuous glucose monitoring system may not improve things much further. Now I am quite sure that some of the patients in the study would say that the CGMS made them feel more secure because they knew what their blood glucose was all the time. There probably were some patients who felt they could push their HbA1c levels closer to normal more safely by having the CGMS but clearly this was not seen in everyone. The study was only six months long, too. Almost any novel treatment will help improve HbA1c in a group of people with diabetes during the first six months, especially if they are being seen up to 14 times by an enthusiastic and supportive research team. I worry that in a "real world" setting where people would get less close supervision and support and where the novelty of the CGMS might wear off after six months that the results might be even more disappointing.
Here are a few other things to think about. None of the people in this study had their CGMS device automatically connected to their insulin pump. This study was not testing an "artificial pancreas" set-up where the continuous glucose readings are automatically transmitted to the insulin pump which then automatically adjusts the insulin dose (I say more about that idea in The Diabetes Answer Book). Studies like that will be done in the next few years and should give interesting results. People who want CGMS because they think it will make their life "easier" may be disappointed, just as people who want an insulin pump so that they won't have to think about their diabetes so much are often disappointed. Both of these technologies can be an amazing help to some people and with more studies we will learn more and more how to use them most effectively.
Truthfully I was expecting the results from this study to be much more impressive. Clearly continuous glucose monitoring systems are not a "magic bullet" to make life with diabetes totally easy. They may be a step in that direction, however, if we can figure out how best to use them.